Mark J Goldberger

Member, Scientific Advisory Committee

Dr Mark Goldberger brings with him a wealth of experience in and in-depth knowledge of infectious diseases and antimicrobial products as well as extensive FDA expertise. Dr Goldberger worked at the FDA in the Center for Drug Evaluation and Research (CDER), including five years as the Director of the Office of Antimicrobial Products and one year in the Center for Biologics Evaluation and Research (CBER) as Medical Director for Emerging and Pandemic Threat Preparedness. Following his time at the FDA, Mark joined Abbott as Divisional Vice President before becoming VP Regulatory Affairs and Senior Advisor following the AbbVie split, providing both regulatory and scientific input into multiple development programs.

He now serves on the SAC of GARDP